ALKemist Bio is a biotechnology company founded in Turin, Italy, in 2023. The company stems from the research of Professor Roberto Chiarle, and is focused on developing a TCR cell therapy targeting the ALK oncogene for ALK-positive cancer patients.
Date of investment December, 2023
Offices Torino, Italy
Roberto Chiarle
Founder
